CLX Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
1.9B
+16.6%
1.7B
-0.2%
1.7B
+17.1%
1.4B
-28.1%
2.0B
Cost of Revenue
1.1B
+20.7%
948.0M
-0.3%
951.0M
+14.2%
833.0M
-21.7%
1.1B
Gross Profit
804.0M
+11.4%
722.0M
+0.0%
722.0M
+21.1%
596.0M
-35.5%
924.0M
Operating Expenses
546.0M
+26.1%
433.0M
-10.0%
481.0M
+2.1%
471.0M
-5.6%
499.0M
R&D
32.0M
+18.5%
27.0M
-6.9%
29.0M
+3.6%
28.0M
-12.5%
32.0M
SG&A
514.0M
+26.6%
406.0M
-10.2%
452.0M
+2.0%
443.0M
-5.1%
467.0M
Operating Income
258.0M
-10.7%
289.0M
+19.9%
241.0M
+92.8%
125.0M
-70.6%
425.0M
EBITDA
336.0M
-3.2%
347.0M
+17.2%
296.0M
+63.5%
181.0M
-62.4%
482.0M
Net Income
167.0M
-12.6%
191.0M
+18.6%
161.0M
+96.3%
82.0M
-75.6%
336.0M
EPS (Basic)
$1.34
-13.0%
$1.54
+19.4%
$1.29
+98.5%
$0.65
-75.9%
$2.70
EPS (Diluted)
$1.34
-13.0%
$1.54
+19.4%
$1.29
+98.5%
$0.65
-75.7%
$2.68
Shares (Diluted)
121.8M
+0.0%
121.8M
-0.1%
121.9M
-0.9%
123.0M
-0.6%
123.7M
Clorox (CLX) โ€” Financials